Search clinical trials for: Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine
Total 2023 results
-
Hellenic Oncology Research GroupTerminated
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
Radboud University Medical CenterUnknownLiver Neoplasms | Colorectal NeoplasmsNetherlands
-
Geriatric Oncology ConsortiumSanofiTerminatedNeoplasm Metastasis | Colorectal CancerUnited States
-
Falo, Louis, MDNational Cancer Institute (NCI)RecruitingCutaneous Squamous Cell Carcinoma | Skin Cancers - Squamous Cell CarcinomaUnited States
-
Yale UniversityNational Cancer Institute (NCI)TerminatedDoxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsMetastatic Cancer | Islet Cell Tumor | Gastrointestinal Carcinoid TumorUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
Roswell Park Cancer InstituteTerminatedColorectal CancerUnited States
-
Hoffmann-La RocheCompletedLiver CancerHong Kong, Taiwan, Singapore, Australia
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Instituto Nacional de Cancerologia, ColumbiaUnknown
-
M.D. Anderson Cancer CenterNot yet recruitingTriple Negative Breast Cancer | Stage 1 cT1b-T1cN0M0United States
-
ETOP IBCSG Partners FoundationCompleted
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Canada, Russian Federation, United States, Argentina, United Kingdom
-
Oslo University HospitalScandinavian Sarcoma GroupUnknownSoft Tissue Sarcoma | Non Metastatic DiseaseSweden
-
Bio-Path Holdings, Inc.RecruitingFallopian Tube Neoplasms | Carcinoma, Ovarian Epithelial | Solid Tumor | Endometrial Cancer | Peritoneal Cancer | Solid Tumor, AdultUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
The University of Texas Health Science Center,...UnknownBreast Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Cervix NeoplasmsUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownColorectal Cancer | Metastatic Cancer | Colorectal AdenocarcinomaChina
-
Janssen Research & Development, LLCCompletedMultiple MyelomaAustralia, France, Poland, United Kingdom, United States, Spain, Israel, Portugal, South Africa, Canada, Netherlands, Belgium, Singapore, Russian Federation, Czech Republic, Argentina, Austria
-
AlfacellUnknownMalignant MesotheliomaUnited States, Poland, Italy, Germany
-
European Organisation for Research and Treatment...Medical Research CouncilCompletedSarcomaFrance, Saudi Arabia, Denmark, Belgium, Netherlands, Portugal, Slovenia, United Kingdom
-
University of NebraskaNational Cancer Institute (NCI)CompletedLymphoma | Cardiac Toxicity | Chemotherapeutic Agent ToxicityUnited States
-
OnxeoCompletedCarcinoma, HepatocellularItaly, Spain, United States, Belgium, Austria, France, Egypt, Germany, Hungary, Turkey, Lebanon
-
Hoffmann-La RocheCompleted
-
Innovent Biologics (Suzhou) Co. Ltd.WuXi CDS Clinical Research (Shanghai) Co.Ltd.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); NCIC Clinical Trials GroupCompletedBreast CancerUnited States, Canada, Peru
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Swiss Group for Clinical Cancer ResearchRecruitingAdvanced Solid TumorsSwitzerland
-
TTY BiopharmActive, not recruiting
-
Astellas Pharma IncAgensys, Inc.TerminatedCarcinoma | Ovarian Diseases | Ovarian Neoplasms | Ovarian CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBevacizumab | Capecitabine | Metastatic Colorectal Cancer (mCRC) | Oxaliplatin | Tislelizumab | First-Line | MSS/pMMR | RAS-mutatedChina
-
UNICANCERCompleted
-
European Organisation for Research and Treatment...CompletedSarcomaFrance, Denmark, Poland, Belgium, Netherlands, United Kingdom, Germany, Hungary, Slovakia, Spain
-
NYU Langone HealthCompletedBreast Cancer | Solid Tumor | Metastatic Breast Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCSPC Ouyi Pharmaceutical Co., Ltd.Recruiting
-
TTY BiopharmUnknownMetastatic Breast CancerTaiwan
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Washington University School of MedicineWithdrawn
-
Shanghai Yizhong Pharmaceutical Co., Ltd.RecruitingMetastatic Breast Cancer (MBC)China
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States
-
Nanjing Sike Pharmaceutical Co., Ltd.Unknown
-
Lund University HospitalHoffmann-La RocheCompleted
-
Spanish Breast Cancer Research GroupSchering-PloughCompletedBreast CancerSpain
-
AbbVie (prior sponsor, Abbott)CompletedOvarian CancerUnited States, Australia, Canada, Hungary, Israel, New Zealand, Poland, United Kingdom